ARMD program (Angstrom Pharmaceuticals)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameARMD program (Angstrom Pharmaceuticals)
Drug Alias Nameage-related macular degeneration therapy (Angstrom Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSplash Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSplash Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A